CN102940848A - Traditional Chinese medicine medicinal liquor for treatment of coronary heart disease - Google Patents
Traditional Chinese medicine medicinal liquor for treatment of coronary heart disease Download PDFInfo
- Publication number
- CN102940848A CN102940848A CN2012103906517A CN201210390651A CN102940848A CN 102940848 A CN102940848 A CN 102940848A CN 2012103906517 A CN2012103906517 A CN 2012103906517A CN 201210390651 A CN201210390651 A CN 201210390651A CN 102940848 A CN102940848 A CN 102940848A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- heart disease
- medicinal liquor
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a traditional Chinese medicine medicinal liquor for treatment of coronary heart disease, which is made from the following Chinese medicine raw materials by weight: 500-600 parts of liquor of 54% -68%, 15-20 parts of cicada slough, 10-20 parts of lumbricus, 10-15 parts of cattail pollen, 10-20 parts of trogopterus dung, 5-10 parts of turmeric root-tuber, 10-15 parts of rhizoma acori graminei, 30-40 parts of radix salviae miltiorrhizae, 30-40 parts of astragalus membranaceus, 20-30 parts of suberect spatholobus stem, 10-20 parts of inula flower, 8-12 parts of white atractylodes rhizome, 10-15 parts of trichosanthes peel, 5-10 parts of roughhaired holly root, 10-15 parts of cassia twig, 5-8 parts of radix achyranthis bidentatae, 5-8 parts of dried tangerine peel, 8-12 parts of scorpio, and 4-6 parts of centipede. The combination of the medicines in the medicinal liquor has the efficacy of well expanding coronary artery, improving microcirculation, improving myocardial ischemia and hypoxia, and enhancing immunity of human bodies. The medicinal liquor of the present invention can improve body's immunologic function, has the efficacy of boosting qi and nourishing yin, and nourishing heart and tonifying lung, has a good effect on patients with coronary heart disease having palpitation and shortness of breath, has no adverse reactions, and is safe in clinical application.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, be specifically related to a kind of Traditional Chinese medicinal liquor for the treatment of coronary heart disease.
Background technology
The coronary heart disease full name is coronary atherosclerotic heart disease, is called again ischemic heart desease.Because serious atherosis luminal stenosis or the obstruction of causing occurs coronary artery, or merge on this basis spasm, thrombosis increases the weight of tube chamber blocks, and causes the coronary insufficiency of nutrition heart, a kind of heart disease of myocardial ischemia, anoxia or generation infarction.Can be with other symptoms, tight such as gas, faint, edema, belch etc., pain mainly is positioned at the breastbone rear portion, can be radiated to pareordia and left upper extremity, often betides work or when excited, continues several minutes.The multiple male who is born in more than 45 years old of primary disease, tired, excited more than 55 years old or postclimacteric women, to be satiated with food, to catch cold, rainy weather, acute circulatory failures etc. are common inducement.
Modern medicine shows, the basic pathological changes of coronary heart disease is the cirrhosis of coronary artery medicated porridge sample, and its morbidity is relevant with factors such as hyperlipidemia, diabetes, hypertension, obesities.Cause mainly due to the rising of the low density lipoprotein, LDL in the blood (LDL) level and vascular endothelial injury.Treating clinically angina pectoris often selects nitrate esters to expand the blood vessel medicine.Sorbitrate is the antianginal drug of generally acknowledging both at home and abroad in the nitrate esters, but its side effect such as headache feeling of fullness in the head that cause is fairly obvious, and drug resistance is arranged.In the last few years, use the auxiliary or alternative traditional mononitrate ester healer of Chinese medicine, became the focus of clinical research.
Summary of the invention
The purpose of this invention is to provide a kind of Traditional Chinese medicinal liquor for the treatment of coronary heart disease.Chinese medicine thinks, coronary heart disease belongs to the disease of the channels of heart and nutrition heart.Because worn with age, function is deficient, and yin and yang qi and blood disorder adds the impact of the factors such as internal injury caused by excess of seven emotions, eating and drinking without temperance, cold stimulation, work and rest mistake degree, causes qi depression to blood stasis, hypofunction of YANG QI in chest, and the turbid interior life of expectorant makes blockage of the cardiac vessels and causes a disease.According to the dialectical theory of Chinese medicine, start with from integral body, adjust body and reach balance, reach the purpose of effecting a permanent cure.
The objective of the invention is to be achieved through the following technical solutions:
The Traditional Chinese medicinal liquor of this treatment coronary heart disease is made by the raw material of Chinese medicine of following weight portion: 54%-68% Chinese liquor 500-600 part, Periostracum Cicadae 15-20 part, Pheretima 10-20 part, Pollen Tyjphae 10-15 part, Oletum Trogopterori 10-20 part, Radix Curcumae 5-10 part, Rhizoma Acori Graminei 10-15 part, Radix Salviae Miltiorrhizae 30-40 part, Radix Astragali 30-40 part, Caulis Spatholobi 20-30 part, Flos Inulae 10-20 part, Rhizoma Atractylodis Macrocephalae 8-12 part, Pericarpium Trichosanthis 10-15 part, Radix Ilicis Asprellae 5-10 part, Ramulus Cinnamomi 10-15 part, Radix Achyranthis Bidentatae 5-8 part, Pericarpium Citri Reticulatae 5-8 part, Scorpio 8-12 part, Scolopendra 4-6 part.
Preferably, the Traditional Chinese medicinal liquor of this treatment coronary heart disease is made by the raw material of Chinese medicine of following weight portion: 560 parts of 58% Chinese liquor, 18 parts of Periostracum Cicadaes, 12 parts of Pheretimas, 15 parts of Pollen Tyjphae, 16 parts of Oletum Trogopteroris, 8 parts of Radix Curcumaes, 15 parts of Rhizoma Acori Graminei, 36 parts of Radix Salviae Miltiorrhizaes, 40 parts of the Radixs Astragali, 24 parts of Caulis Spatholobis, 18 parts of Flos Inulae, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Pericarpium Trichosanthiss, 10 parts of Radix Ilicis Asprellaes, 15 parts of Ramulus Cinnamomi, 8 parts of Radix Achyranthis Bidentataes, 6 parts of Pericarpium Citri Reticulataes, 12 parts of Scorpios, 5 parts of Scolopendras.
Described Traditional Chinese medicinal liquor makes by the following method: by above-mentioned formulation ratio Chinese medicine is put into container, add Chinese liquor, sealing is positioned over the lucifuge place and soaks 40-50d, and after filtering bottling gets final product.
Each 20-30ml, every day 3 times is oral, and 4 weeks were a course for the treatment of, serve on 3-4 the course for the treatment of.
The diuresis that relieves the pain of Periostracum Cicadae, Pheretima, Scorpio, Scolopendra relieving spasm by subduing liver-wind, detoxicating and resolving stagnation of pathogens, cleaning heat and expelling wind, collateral dredging; The Radix Salviae Miltiorrhizae activating blood circulation to dissipate blood stasis, removing heat from blood is capable to stagnate nourishing blood to tranquillize the mind; Caulis Spatholobi, the circulation of qi promoting of Radix Achyranthis Bidentatae activating blood and removing stasis, dispeling the wind relieves the pain; Pollen Typhae, Oletum Trogopterori, Radix Curcumae activating blood circulation to dissipate blood stasis, promoting QI circulation for relieving depression; Pericarpium Trichosanthis, Flos Inulae, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae reduce phlegm except the chest stuffiness relieving in painful abdominal mass, the accent of regulating the flow of vital energy; Ramulus Cinnamomi is analgesic to promote the production of body fluid warming the meridian for promoting the flow of YANG QI; Radix Ilicis Asprellae, the Radix Astragali, Rhizoma Acori Graminei tonifying Qi and lifting yang, resuscitation inducing and mind tranquilizing.
All medicines share and have good coronary artery dilator, improve microcirculation in the Traditional Chinese medicinal liquor of the present invention, improve the effect of myocardial ischemia and anoxia, enhancing body resistance.Traditional Chinese medicinal liquor of the present invention can improve the immunologic function of body, has benefiting qi and nourishing yin, an effect of the tonifying the lung that nourishes heart, and the patients with coronary heart disease of deficiency of both QI and YIN, shortness of breath and palpitation is had preferably curative effect, and the generation that has no adverse reaction, clinical practice safety.
In February, 2008 to 2012 year JIUYUE Drug therapy patients with coronary heart disease 231 examples of the present invention are cured 198 examples, 21 examples that take a turn for the better, and 12 examples that do not heal, cure rate reaches 86%, and total effective rate reaches 95%.
Efficacy evaluation: cure: continuous three days, it is normal that heart rate recovers, transference cure; Take a turn for the better: sx↓; Do not heal: heart rate, symptom are unchanged.
The specific embodiment
Embodiment 1
The Traditional Chinese medicinal liquor for the treatment of coronary heart disease is made by the raw material of Chinese medicine of following weight portion: 520 parts of 62% Chinese liquor, 20 parts of Periostracum Cicadaes, 15 parts of Pheretimas, 12 parts of Pollen Tyjphae, 18 parts of Oletum Trogopteroris, 6 parts of Radix Curcumaes, 12 parts of Rhizoma Acori Graminei, 40 parts of Radix Salviae Miltiorrhizaes, 35 parts of the Radixs Astragali, 30 parts of Caulis Spatholobis, 15 parts of Flos Inulae, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Pericarpium Trichosanthiss, 6 parts of Radix Ilicis Asprellaes, 12 parts of Ramulus Cinnamomi, 6 parts of Radix Achyranthis Bidentataes, 8 parts of Pericarpium Citri Reticulataes, 10 parts of Scorpios, 6 parts of Scolopendras.
The Traditional Chinese medicinal liquor for the treatment of coronary heart disease makes by the following method: by above-mentioned formulation ratio Chinese medicine is put into container, add Chinese liquor, sealing is positioned over the lucifuge place and soaks 45d, and after filtering bottling gets final product.
Embodiment 2
The Traditional Chinese medicinal liquor for the treatment of coronary heart disease is made by the raw material of Chinese medicine of following weight portion: 560 parts of 58% Chinese liquor, 18 parts of Periostracum Cicadaes, 12 parts of Pheretimas, 15 parts of Pollen Tyjphae, 16 parts of Oletum Trogopteroris, 8 parts of Radix Curcumaes, 15 parts of Rhizoma Acori Graminei, 36 parts of Radix Salviae Miltiorrhizaes, 40 parts of the Radixs Astragali, 24 parts of Caulis Spatholobis, 18 parts of Flos Inulae, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Pericarpium Trichosanthiss, 10 parts of Radix Ilicis Asprellaes, 15 parts of Ramulus Cinnamomi, 8 parts of Radix Achyranthis Bidentataes, 6 parts of Pericarpium Citri Reticulataes, 12 parts of Scorpios, 5 parts of Scolopendras.
The Traditional Chinese medicinal liquor for the treatment of coronary heart disease makes by the following method: by above-mentioned formulation ratio Chinese medicine is put into container, add Chinese liquor, sealing is positioned over the lucifuge place and soaks 45d, and after filtering bottling gets final product.
Model case
Case 1: Zhu, man, 65 years old, Zhu Wang people from village, Hei Ta town, suffer from the mental and physical efforts latent coronary heart disease for many years, took Chinese medicine decoction of the present invention in 2009 to treat, take a turn for the better when taking 2 months, the number of times that symptom occurs greatly reduces, after serveing on 3 courses for the treatment of, transference cure check to recover normal, after recurrence.
Case 2: Lee, the woman, 68 years old, Wu Zong people from village, Cao Miao town occurred laboring for breath when movable, shortness of breath in 2008, conscious physically-draining, slightly labor is namely felt painstakingly, feels to have palpitation, breathe hard, and is unequal to one's responsibility, heart failure appears when serious, be diagnosed as heart failure type coronary heart disease, many places treatments is thoroughly cured, and begins upon somebody's introduction to take Chinese medicine decoction of the present invention in 2009, take a turn for the better when taking 1 month, the morbidity number of times greatly reduce, serve on 3 courses for the treatment of after, transference cure, check to recover normal, after recurrence.
Case 3: Wang, the man, 48 years old, Kai Zhuan people from village, pier market town, that health in 2009 occurs is uncomfortable in chest, chest pain, the symptom of breathing hard, chest pain shows as chest compressing sensation of asphyxia, vexed swollen sense, the violent sample pain of burning, with collapse, perspiration, short of breath, worry, cardiopalmus, feel sick or the symptom such as dizzy.Be diagnosed as angina pectoris coronary heart disease, do not cure through the various big hospital treatment, outbreak causes very big misery to patient repeatedly, began in rear 2010 with Chinese medicine decoction of the present invention, take a turn for the better when taking 2 months, the number of times that symptom occurs obviously reduces, serve on 3 courses for the treatment of after, transference cure check to recover normal, after recurrence.
Claims (3)
1. Traditional Chinese medicinal liquor for the treatment of coronary heart disease, it is characterized in that, made by the raw material of Chinese medicine of following weight portion: 54%-68% Chinese liquor 500-600 part, Periostracum Cicadae 15-20 part, Pheretima 10-20 part, Pollen Tyjphae 10-15 part, Oletum Trogopterori 10-20 part, Radix Curcumae 5-10 part, Rhizoma Acori Graminei 10-15 part, Radix Salviae Miltiorrhizae 30-40 part, Radix Astragali 30-40 part, Caulis Spatholobi 20-30 part, Flos Inulae 10-20 part, Rhizoma Atractylodis Macrocephalae 8-12 part, Pericarpium Trichosanthis 10-15 part, Radix Ilicis Asprellae 5-10 part, Ramulus Cinnamomi 10-15 part, Radix Achyranthis Bidentatae 5-8 part, Pericarpium Citri Reticulatae 5-8 part, Scorpio 8-12 part, Scolopendra 4-6 part.
2. a kind of Traditional Chinese medicinal liquor for the treatment of coronary heart disease according to claim 1, it is characterized in that, made by the raw material of Chinese medicine of following weight portion: 560 parts of 58% Chinese liquor, 18 parts of Periostracum Cicadaes, 12 parts of Pheretimas, 15 parts of Pollen Tyjphae, 16 parts of Oletum Trogopteroris, 8 parts of Radix Curcumaes, 15 parts of Rhizoma Acori Graminei, 36 parts of Radix Salviae Miltiorrhizaes, 40 parts of the Radixs Astragali, 24 parts of Caulis Spatholobis, 18 parts of Flos Inulae, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Pericarpium Trichosanthiss, 10 parts of Radix Ilicis Asprellaes, 15 parts of Ramulus Cinnamomi, 8 parts of Radix Achyranthis Bidentataes, 6 parts of Pericarpium Citri Reticulataes, 12 parts of Scorpios, 5 parts of Scolopendras.
3. the Traditional Chinese medicinal liquor for the treatment of coronary heart disease according to claim 1, it is characterized in that, described Traditional Chinese medicinal liquor makes by the following method: by above-mentioned formulation ratio Chinese medicine is put into container, add Chinese liquor, sealing is positioned over the lucifuge place and soaks 40-50d, and after filtering bottling gets final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103906517A CN102940848A (en) | 2012-10-16 | 2012-10-16 | Traditional Chinese medicine medicinal liquor for treatment of coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103906517A CN102940848A (en) | 2012-10-16 | 2012-10-16 | Traditional Chinese medicine medicinal liquor for treatment of coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102940848A true CN102940848A (en) | 2013-02-27 |
Family
ID=47723908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012103906517A Pending CN102940848A (en) | 2012-10-16 | 2012-10-16 | Traditional Chinese medicine medicinal liquor for treatment of coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102940848A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103989976A (en) * | 2014-04-21 | 2014-08-20 | 史家举 | Traditional Chinese medicine composition for treating coronary heart disease |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN1347709A (en) * | 2000-10-09 | 2002-05-08 | 王学勇 | Cardiac and cerebral vascular disease treating medicine |
| CN101690764A (en) * | 2009-09-30 | 2010-04-07 | 卢速江 | Traditional Chinese medicine for treating cardiac, cerebral and vascular diseases and preparation method thereof |
| CN101991816A (en) * | 2010-11-12 | 2011-03-30 | 李奕星 | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
-
2012
- 2012-10-16 CN CN2012103906517A patent/CN102940848A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1347709A (en) * | 2000-10-09 | 2002-05-08 | 王学勇 | Cardiac and cerebral vascular disease treating medicine |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN101690764A (en) * | 2009-09-30 | 2010-04-07 | 卢速江 | Traditional Chinese medicine for treating cardiac, cerebral and vascular diseases and preparation method thereof |
| CN101991816A (en) * | 2010-11-12 | 2011-03-30 | 李奕星 | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103989976A (en) * | 2014-04-21 | 2014-08-20 | 史家举 | Traditional Chinese medicine composition for treating coronary heart disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102670928B (en) | Plaster for treating cervical spondylosis and lumbar spondylosis | |
| CN105561214A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN102940865A (en) | Externally applied medicament for treating rheumatoid arthritis and hyperosteogeny and preparation method thereof | |
| CN102283923B (en) | Blood circulation promoting and swelling and pain relieving powder for trauma | |
| CN100512852C (en) | Composite Chinese medicine took orally for treating coronary heart disease | |
| CN102008698A (en) | Traditional Chinese medicine composition and preparation for curing dysmenorrhea | |
| CN102579750B (en) | Traditional Chinese medicine composition for treating primary dysmenorrhea | |
| CN102940848A (en) | Traditional Chinese medicine medicinal liquor for treatment of coronary heart disease | |
| CN102600251B (en) | Rheumatism-rehabilitating traditional Chinese formulation | |
| CN103191286A (en) | Traditional Chinese medicine for treating temporomandibular disorders | |
| CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
| CN101301394B (en) | Medicament for treating rheumatoid disease | |
| CN101195002B (en) | Chinese medicine emplastrum for releasing ache and health care | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN102139027B (en) | Medicinal liquor for treating rheumatic arthritis | |
| CN103055159B (en) | Medicine for treating hypertension | |
| CN101417080B (en) | Traditional Chinese medicine preparation for treating rheumatic heart disease | |
| CN102406789B (en) | Plaster for treating cervical spondylosis | |
| CN100548336C (en) | A kind of Chinese medicine composition of orally taken for curing intercostal neuralgia | |
| CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
| CN105287979A (en) | External-application traditional Chinese medicine for treating cervical spondylosis | |
| CN105194105A (en) | Traditional Chinese medicine treating heart blood insufficiency type cardiac arrhythmia | |
| CN104096112A (en) | Traditional Chinese medicine composition for treating angina pectoris | |
| CN102697882A (en) | Angelica-containing Chinese medicinal oral liquid for treating chronic hepatitis and preparation method | |
| CN102743437A (en) | Traditional Chinese medicine composition having function of clearing vivotoxin and preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130227 |